Dr. Asghari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44151 15th Street West
Lancaster, CA 93534Phone+1 661-902-5600Fax+1 661-951-0686- Is this information wrong?
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
- Johns Hopkins UniversityResidency, Internal Medicine, 2014 - 2017
- University of Florida College of MedicineClass of 2014
Certifications & Licensure
- FL State Medical License 2017 - 2025
- CA State Medical License Active through 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Liposomal encapsulated cytarabine and daunorubicin (CPX-351) for older patients with acute myeloid leukemiaHannah Asghari, Jeffrey E. Lancet> ;Leukemia & Lymphoma. 2020 Feb 8
- 5 citationsTumor protein 53 mutations in acute myeloid leukemia: conventional induction chemotherapy or novel therapeutics.Hannah Asghari, Chetasi Talati> ;Current Opinion in Hematology. 2020 Jan 9
Abstracts/Posters
- RUNX1 Mutation Is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia Receiving Allogeneic Stem Cell TransplantationHannah H Asghari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts OutcomeHannah Asghari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell TransplantationHannah Asghari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Outcomes of Patients with Relapsed or Refractory Acute Myeloid Leukemia Receiving Hypomethylating Agent and Venetoclax61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Conventional Real Time Quantitative Polymerase Chain Reaction Method Yields Similar Level of Sensitivity to Digital Droplet Polymerase Chain Reaction for Detection of ...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hypomethylating Agent and Venetoclax Combination Yields Comparable Outcomes to CPX-351 in Newly Diagnosed Acute Myeloid Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: